Osteoporosis Links
|
|
|
| More
Osteoporosis Information |
| |
| |
| |
|
|
|
Osteoporosis Information
Definition |
Osteoporosis,
or porous bone, is a disease characterized by
low bone mass and structural deterioration of
bone tissue, leading to bone fragility and an
increased susceptibility to fractures,
especially of the hip, spine and wrist, although
any bone can be affected. |
|
Prevalence |
Osteoporosis
is a major public health threat for an estimated
44 million Americans, or 55 percent of the
people 50 years of age and older. In the U.S.
today, 10 million individuals are estimated to
already have the disease and almost 34 million
more are estimated to have low bone mass,
placing them at increased risk for osteoporosis.
Of the 10
million Americans estimated to have
osteoporosis, eight million are women and 2
million are men.
Thirty-four
million Americans have low bone mass, which puts them at
increased risk of developing osteoporosis and
related fractures.
One in two
women and one in four men over age 50 will have
an osteoporosis-related fracture in her/his
remaining lifetime.
Significant
risk has been reported in people of all ethnic
backgrounds.
While
osteoporosis is often thought of as an older
person's disease, it can strike at any age.
Women
Eighty
percent of those affected by osteoporosis are
women.
Five percent
of non-Hispanic black women over age 50 are
estimated to have osteoporosis; an estimated
additional 35 percent have low bone mass that
puts them at risk of developing osteoporosis.
Ten percent
of Hispanic women aged 50 and older are
estimated to have osteoporosis, and 49 percent
are estimated to have low bone mass.
Twenty
percent of non-Hispanic white and Asian women
aged 50 and older are estimated to have
osteoporosis, and 52 percent are estimated to
have low bone mass.
Men
Twenty
percent of those affected by osteoporosis are
men.
Seven percent
of non-Hispanic white and Asian men aged 50 and
older are estimated to have osteoporosis and 35
percent are estimated to have low bone mass.
Four percent
of non-Hispanic black men aged 50 and older are
estimated to have osteoporosis and 19 percent
are estimated to have low bone mass.
Three percent
of Hispanic men aged 50 and older are estimated
to have osteoporosis and 23 percent are
estimated to have low bone mass.
Fractures
One in two
women and one in four men over age 50 will have
an osteoporosis-related fracture in their
remaining lifetime.
Osteoporosis
is responsible for more than 1.5 million
fractures annually, including:
-
over
300,000 hip fractures; and
approximately
-
700,000
vertebral fractures;
-
250,000
wrist fractures; and
-
300,000
fractures at other sites.
|
| Cost |
The
estimated national direct expenditures
(hospitals and nursing homes) for osteoporotic
hip fractures was $18 billion in 2002, and the
cost is rising. |
| Symptoms |
Osteoporosis
is often called the "silent disease" because
bone loss occurs without symptoms. People may
not know that they have osteoporosis until their
bones become so weak that a sudden strain, bump
or fall causes a fracture or a vertebra to
collapse. Collapsed vertebrae may initially be
felt or seen in the form of severe back pain,
loss of height, or spinal deformities such as
kyphosis or stooped posture. |
| Risk Factors |
Certain
people are more likely to develop osteoporosis
than others. Factors that increase the
likelihood of developing osteoporosis are called
"risk factors." These risk factors include:
-
Personal history of fracture after age 50
-
Current
low bone mass
-
History
of fracture in a 1° relative
-
Being
female
-
Being
thin and/or having a small frame
-
Advanced age
-
A
family history of osteoporosis
-
Estrogen deficiency as a result of menopause,
especially early or surgically induced
-
Abnormal absence of menstrual periods
(amenorrhea)
-
Anorexia nervosa
-
Low
lifetime calcium intake
-
Vitamin
D deficiency
-
Use of
certain medications, such as corticosteroids
and anticonvulsants
-
Presence of certain chronic medical conditions
-
Low
testosterone levels in men
-
An
inactive lifestyle
-
Current
cigarette smoking
-
Excessive use of alcohol
-
Being
Caucasian or Asian, although African Americans
and Hispanic
Americans are at significant risk as well
Women can
lose up to 20 percent of their bone mass in the
five to seven years following menopause, making
them more susceptible to osteoporosis.
|
| Detection |
Specialized
tests called bone density tests can measure bone
density in various sites of the body. A bone
density test can:
|
| Prevention |
By about age
20, the average woman has acquired 98 percent of
her skeletal mass. Building strong bones during
childhood and adolescence can be the best
defense against developing osteoporosis later.
There are five steps, which together, can
optimize bone health and help prevent
osteoporosis. They are:
-
A balanced
diet rich in calcium and vitamin D;
-
Weight-bearing exercise;
-
A healthy lifestyle with no smoking or excessive
alcohol intake;
-
Talking to your healthcare professional about
bone health; and
-
Bone
density testing and medication when
appropriate.
|
| Fractures |
The most
typical sites of fractures related to
osteoporosis are the hip, spine, wrist and ribs,
although the disease can affect any bone in the
body.
The rate of
hip fractures is two to three times higher in
women than men; however the one year mortality
following a hip fracture is nearly twice as high
for men as for women.
A woman's
risk of hip fracture is equal to her combined
risk of breast, uterine and ovarian cancer.
In 1991,
about 300,000 Americans age 45 and over were
admitted to hospitals with hip fractures.
Osteoporosis was the underlying cause of most of
these injuries.
An average of
24 percent of hip fracture patients aged 50 and
over die in the year following their fracture.
One-fourth of
those who were ambulatory before their hip
fracture require long-term care afterward.
At six months
after a hip fracture, only 15% of hip fracture
patients can walk across a room unaided.
White women
65 or older have twice the incidence of
fractures as African-American women. |
Fosamax Osteoporosis Information
Fosamax ( generic name - Alendronate
) is a type of drug known as bisphosphonates. Recently a link
has been found between bisphosphonates and a serious bone disease called
osteonecrosis of the jaw ( ONJ ). This important discovery clearly
shows that Fosamax side effects may include
osteonecrosis of the jaw. The discovery, published in the Journal of Oral and
Maxillofacial Surgeons, prompted both the US, Food and Drug Administration (
FDA ) and Novartis, the manufacturer of bisphosphonates used in cancer
chemotherapy, to issue a warning to health care professionals on September 24,
2004. The warning letter contained information about bisphosphonates
and the risks of osteonecrosis in the jaw.
Bisphosphonates are commonly used in tablet form such
as Fosamax ( Alendronate Sodium ) to prevent and treat osteoporosis in
post-menopausal women. Stronger forms of bisphosphonates are commonly used in
the management of advanced cancers that have metastasized to the bone, where
the disease often causes bone pain and possibly even fractures. Several cancers
can involve or metastasize to the bone, including lung cancer, breast cancer,
prostate cancer, multiple myeloma, and others. When bisphosphonates are given
in cancer chemotherapy, the drugs are given intravenously, and usually for
longer periods of time.
If you or a loved one have taken Fosamax and have been
injured as a result of Fosamax side effects such as osteonecrosis of the jaw
contact today the offices of
Powell
Law Firm, L.C. is the nation's leading law firm for
litigation regarding Bisphosphonate Complications. for your free,
confidential case evaluation at toll-free 888-238-1998 Please state
your name and phone number And we will
get back with you promptly or email us
at info@mpowelllaw.com
www.MPowellLaw.com Accepting Inquiries from the U.S.
and Internationally
Every case is different. No specific results are
implied. 269
South Beverly Drive, Suite 1156, Beverly Hills, CA 90212 . .
Osteonecrosis of the Jaw
Osteonecrosis of the jaw ( ONJ ) is a condition in which the bone tissue in the
jaw fails to heal after minor trauma such as a tooth extraction, causing the
bone to be exposed. The exposure can eventually lead to infection and fracture
and may require long-term antibiotic therapy or surgery to remove the dying
bone tissue. Experts say that prevention and early treatment of individuals
using bisphosphonates such as Fosamax is extremely important in preserving the
jaw bone. Individuals using Fosomax or other bisphosphonates should attempt to
avoid tooth extractions and other major dental work while on the drugs.
Although most cases of osteonecrosis of the jaw related to Fosamax,Zometa, and
Aredia side effects
have occured after dental work several cases have been reported to occur
without any prior dental work. If you are currently taking Fosamax,Zometa,
or Aredia you may be
at risk of developing osteonecrosis. If you have been injured by Fosamax side
effects you may be entitled to compensation. For more information about your
legal rights contact the offices of
Powell
Law Firm, L.C. is the nation's leading law firm for
litigation regarding Bisphosphonate Complications. for your free,
confidential case evaluation at toll-free 888-238-1998 Please state
your name and phone number And we will
get back with you promptly or email us
at info@mpowelllaw.com
www.MPowellLaw.com
Accepting Inquiries from the U.S.
and Internationally
Every case is different. No specific results are
implied. 269
South Beverly Drive, Suite 1156, Beverly Hills, CA 90212
Accepting inquiries from the U.S. and Internationally
|